| Preclinical testing of nalfurafine as an opioid-sparing adjuvant that potentiates analgesia by the mu opioid receptor-targeting agonist morphine SW Kaski, AN White, JD Gross, KR Trexler, K Wix, AA Harland, ... Journal of Pharmacology and Experimental Therapeutics 371 (2), 487-499, 2019 | 37 | 2019 |
| Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice KR Trexler, SR Nass, MS Crowe, JD Gross, MS Jones, AW McKitrick, ... Drug and alcohol dependence 191, 14-24, 2018 | 28 | 2018 |
| Platelet factors attenuate inflammation and rescue cognition in ageing AB Schroer, PB Ventura, J Sucharov, R Misra, MKK Chui, G Bieri, ... Nature 620 (7976), 1071-1079, 2023 | 26 | 2023 |
| Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior JD Gross, SW Kaski, KT Schmidt, ES Cogan, KM Boyt, K Wix, AB Schroer, ... Neuropsychopharmacology 44 (10), 1728-1741, 2019 | 21 | 2019 |
| Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants JD Gross, SW Kaski, AB Schroer, KA Wix, DP Siderovski, V Setola Journal of psychopharmacology 32 (2), 191-203, 2018 | 18 | 2018 |
| Potential for kappa-opioid receptor agonists to engineer nonaddictive analgesics: a narrative review SW Kaski, AN White, JD Gross, DP Siderovski Anesthesia & Analgesia 132 (2), 406-419, 2021 | 17 | 2021 |
| Genetic variations in GPSM3 associated with protection from rheumatoid arthritis affect its transcript abundance BJ Gall, A Wilson, AB Schroer, JD Gross, P Stoilov, V Setola, CM Watkins, ... Genes & Immunity 17 (2), 139-147, 2016 | 12 | 2016 |
| Development of full sweet, umami, and bitter taste responsiveness requires regulator of G protein signaling-21 (RGS21) AB Schroer, JD Gross, SW Kaski, K Wix, DP Siderovski, A Vandenbeuch, ... Chemical senses 43 (5), 367-378, 2018 | 11 | 2018 |
| Reduction of GPSM3 expression akin to the arthritis-protective SNP rs204989 differentially affects migration in a neutrophil model BJ Gall, AB Schroer, JD Gross, V Setola, DP Siderovski Genes & Immunity 17 (6), 321-327, 2016 | 8 | 2016 |
| Ghrelin receptor signaling in health and disease: a biased view JD Gross, Y Zhou, LS Barak, MG Caron Trends in Endocrinology & Metabolism 34 (2), 106-118, 2023 | 7 | 2023 |
| Establishment of multi-stage intravenous self-administration paradigms in mice LM Slosky, A Pires, Y Bai, NB Clark, ER Hauser, JD Gross, F Porkka, ... Scientific reports 12 (1), 21422, 2022 | 7 | 2022 |
| Discovery of a functionally selective ghrelin receptor (GHSR1a) ligand for modulating brain dopamine JD Gross, DW Kim, Y Zhou, D Jansen, LM Slosky, NB Clark, CR Ray, ... Proceedings of the National Academy of Sciences 119 (10), e2112397119, 2022 | 5 | 2022 |
| Genetic deletion of Rgs12 in mice affects serotonin transporter expression and function in vivo and ex vivo AN White, JD Gross, SW Kaski, KR Trexler, KA Wix, WC Wetsel, ... Journal of Psychopharmacology 34 (12), 1393-1407, 2020 | 4 | 2020 |
| The stability of tastant detection by mouse lingual chemosensory tissue requires Regulator of G protein Signaling-21 (RGS21) AB Schroer, KW Branyan, JD Gross, PD Chantler, AJ Kimple, ... Chemical senses 46, bjab048, 2021 | 2 | 2021 |
| Regulator of G Protein Signaling-12 (RGS12) in dopaminergic and kappa opioid receptor-dependent signaling and behavior JD Gross West Virginia University, 2019 | | 2019 |
